Updates on the Activity, Efficacy and Emerging Mechanisms of Resistance to Cefiderocol
Gabriele Bianco(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Paolo Gaibani(Azienda USL di Bologna), Rossella Fonnesu(Azienda Ospedaliera Universitaria Integrata Verona), Matteo Boattini(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Michele Bartoletti(Humanitas University), Milo Gatti(University of Bologna), Lucia Diella(Humanitas University), Vittorio Sambri(Azienda Unità Sanitaria Locale Della Romagna), Caterina Signoretto(University of Verona), Luca Rossi(University of Verona), Monica Cricca(Azienda Unità Sanitaria Locale Della Romagna), Sara Comini(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino)
Cited by 27
Related Papers
Resistance to Ceftazidime/Avibactam, Meropenem/Vaborbactam and Imipenem/Relebactam in Gram-Negative MDR Bacilli: Molecular Mechanisms and Susceptibility Testing
|Antibiotics|2022|117
Colonization and infection due to carbapenemase-producing Enterobacteriaceae in liver and lung transplant recipients and donor-derived transmission: a prospective cohort study conducted in Italy
|Clinical Microbiology and Infection|2018|60
In vitro activity of cefiderocol against ceftazidime-avibactam susceptible and resistant KPC-producing Enterobacterales: cross-resistance and synergistic effects
|European Journal of Clinical Microbiology & Infectious Diseases|2021|51
RESIST-5 O.O.K.N.V. and NG-Test Carba 5 assays for the rapid detection of carbapenemase-producing Enterobacterales from positive blood cultures: a comparative study
|Journal of Hospital Infection|2020|46
Carbapenemase detection testing in the era of ceftazidime/avibactam-resistant KPC-producing Enterobacterales: A 2-year experience
|Journal of Global Antimicrobial Resistance|2021|46